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Abstract
Background: To improve local control rate in patients with breast cancer receiving adjuvant radiotherapy after
breast conservative surgery, additional boost dose to the tumor bed could be delivered simultaneously via the
simultaneous integrated boost (SIB) modulated technique. However, the position of tumor bed kept changing
during the treatment course as the treatment position was aligned to bony anatomy. This study aimed to analyze
the positional uncertainties between bony anatomy and tumor bed, and a topology-based approach was derived
to stratify patients with high variation in tumor bed localization.
Methods: Sixty patients with early-stage breast cancer or ductal carcinoma in situ were enrolled. All received adjuvant
whole breast radiotherapy with or without local boost via SIB technique. The delineation of tumor bed was defined by
incorporating the anatomy of seroma, adjacent surgical clips, and any architectural distortion on computed tomography
simulation. A total of 1740 on-board images were retrospectively analyzed. Positional uncertainty of tumor bed
was assessed by four components: namely systematic error (SE), and random error (RE), through anterior-posterior
(AP), cranial-caudal (CC), left-right (LR) directions and couch rotation (CR). Age, tumor location, and body-mass factors
including volume of breast, volume of tumor bed, breast thickness, and body mass index (BMI) were analyzed for their
predictive role. The appropriate margin to accommodate the positional uncertainty of the boost volume was assessed,
and the new plans with this margin for the tumor bed was designed as the high risk planning target volume (PTV-H)
were created retrospectively to evaluate the impact on organs at risk.
Results: In univariate analysis, a larger breast thickness, larger breast volume, higher BMI, and different tumor
locations correlated with a greater positional uncertainty of tumor bed. However, BMI was the only factor associated
with displacements of surgical clips in the multivariate analysis and patients with higher BMI were stratified as high
variation group. When image guidance was aligned to bony structures, the SE and RE of clip displacement were
consistently larger in the high variation group. The corresponding PTV-H margins for the high- and low-variation groups
were 7, 10, 10 mm and 4, 9, 6 mm in AP, CC, LR directions, respectively. The heart dose between the two plans was not
significantly different, whereas the dosimetric parameters for the ipsilateral lung were generally higher in the new plans.
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Conclusions: In patients with breast cancer receiving adjuvant radiotherapy, a higher BMI is associated with a greater
positional uncertainty of the boost tumor volume. More generous margin should be considered and it can be safely
applied through proper design of beam arrangement with advanced treatment techniques.
Keywords: Breast cancer, Adjuvant radiotherapy, Tumor bed uncertainty, Simultaneous integrated boost
Background
Breast conservative therapy including lumpectomy and
adjuvant whole breast radiotherapy has become standard
treatment for patient with early stage breast cancer
[1, 2]. Additional boost dose to the tumor bed via electron
or photon beam further improve local control rate [3].
Treatment techniques with beam arrangement using the
tangent angles can have a limited dose to the ipsilateral
lung and the contralateral breast but are difficult to
generate a concave dose distribution conforming to the
breast target. Advanced techniques like intensity-modulated
radiation therapy (IMRT), tomotherapy, and volumetric
intensity-modulated arc radiation therapy (VMAT) offer
the ability to provide a more sophisticated process through
the inverse planning procedure, generating a more con-
formal dose distribution to the breast target, sparing
the high dose region to the anterior heart, and improving
dose homogeneity [4–8]. Through proper design of beam
arrangement with advanced treatment techniques, plans
possessing a concave dose distribution with limited doses
to the critical heart, lung, and contralateral breast should
be achievable. In our institution, most of patients received
boost dose with a simultaneous integrated boost (SIB)
modulated technique. With the use of SIB technique,
accuracy of dose delivery to the tumor bed is essential
for proper treatment. Surgical clips in the peripheral of
the tumor bed have been evaluated in several studies as
the fiducial marker to improve the boost accuracy [9–12].
A study from Italy investigated the role of surgical clips in
defining the clinical target volume (CTV) for partial breast
irradiation. They conclude that surgical clips are essential
and six or more increase the accuracy of tumor bed
localization [11]. However, the position of tumor bed kept
changing during the treatment course as the treatment
position was aligned to bony anatomy and there is no
consistency in positioning between bony structures and
surgical clips during daily image guidance [12].
The aim of the current study was to compare the
positional uncertainty between bony anatomy and surgical
clip of tumor bed. In addition, the impact of body-mass
factors (BMF) on magnitude of surgical clip displacements
was determined. A topology-based approach was derived
to stratify patients with high variation of tumor-bed pos-
ition, and the corresponding margin of high risk planning
target volume (PTV-H) was evaluated to accommodate
the dose coverage of tumor-bed. This method would
provide an accurate, efficient, and cost-effective clinical
application.
Methods
Patients and treatment concept
With the approval of the local institutional review board,
60 consecutive patients with early-stage, node-negative
breast cancers diagnosed in between 2014 and 2015
were enrolled. Forty-eight patients were victims of inva-
sive cancer, after partial mastectomy and sentinel lymph
node biopsy, all received adjuvant whole breast radio-
therapy using a SIB technique with median dose of
5880 cGy to tumor bed and 5040 cGy to whole breast
in 28 fractions under daily image guidance. The other
12 patients with carcinoma in situ underwent adjuvant
whole breast radiotherapy of 5040 cGy in 28 fractions
without local boost. Surgical clips marking the position of
the tumor bed had been implanted at the time of breast-
conserving surgery. Patient-related factors consisted of
age, tumor location, and body mass factors were acquired
from chart record and simulation computed tomographic
(CT) images. Body mass factors included body weight,
body height, body mass index (BMI), volume of breast,
volume of tumor bed, and breast thickness. Breast
thickness was defined by the distance between the chest
wall and the skin surface at the level of the nipple [13].
Detail of patient characters was illustrated in Table 1.
Treatment planning
To enhance the accuracy of the daily irradiated position,
custom-made immobilization device with ipsilateral arm
raised was used for all patients. Following fabrication of
the immobilization device, simulation using a CT simula-
tor (HiSpeed NX/i, GE Healthcare, Milwaukee, Wisconsin,
USA) was performed with free breathing and 4-mm-slice
thickness. Treatment target contouring was completed
according to the RTOG consensus atlas [14]. The CTV
included the whole lesion-sided breast, and a margin of
5 mm extended isotropically from the CTV to form the
PTV. The delineation of tumor bed (CTV-H) was defined
by incorporating the anatomy of seroma, adjacent surgical
clips and any architectural distortion on the CT image.
For those without tumor bed boost, the surgical clips and
CTV-Hs were still contoured for localization. All cases
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with invasive cancer were planned with a concomitant
boost delivered in 28 fractions by intensity modulated
radiotherapy (IMRT) technique using 6 MV photon
beams. The prescribed dose of 5880 cGy to the CTV-H
and 5040 cGy to the PTV via 4 to 5-field IMRT was
planned (Fig. 1). Two tangential beams were assigned
to the PTV and another oblique beams assigned to the
CTV-H. The beam angle was adjusted according to the
location of tumor bed and critical organs. In the original
plan, there was no additional margin added to the CTV-H.
All plans were carried out using the Eclipse treatment
planning system (Version 11, Varian Medical Systems Inc,
Palo Alto, California, USA) with Analytical Anisotropic
Algorithm (AAA) for dose calculation.
Verification of treatment position and data acquisition
All patients were treated under daily image guidance with
the Varian Clinac iX Linac (Varian Medical Systems, Palo
Alto, California, USA) equipped with an on-line On-
Board Imaging (OBI) system. In daily treatment, after
patients were set up according to the skin markers,
two orthogonal plane images were taken for image
registration. Bony structure such as upper sternum
and ribs were used as matching positions by two radiation
therapists. Then, an attending physician would check and
confirm the registered images. We retrospectively reg-
istered a total of 1740 daily on-board images to the
pretreatment digital reconstruction radiography, and
the images were re-matched using surgical clips as
surrogates.
The positional uncertainty was compared between bony
anatomy and surgical clip of tumor bed, and treatment
target displacements for each patient were assessed by four
metrics: namely systemic error (SE, ∑), and random error
(RE, σ), through three translational directions anterior-
posterior (AP), cranial-caudal (CC) and left – right (LR) as
well as couch rotation (CR). The ∑ is defined as the
variation of the mean error between patients, while the σ
represents the root mean square (RMS) of the standard
deviations (SD’s) of all patients [15].
Margin assessment and treatment plan comparison
As a consequence of daily target uncertainty, we disclosed
the additional margin, namely PTV-H, of 2.5 ∑ + 0.7
σ should be added around tumor bed by the proposal
from Van Herk et al. [16]. We adapted a new plan with
the PTV-H for the 48 patients with invasive cancer, and
the dose to the target, the heart and the ipsilateral lung
were compared between the original and new plans. The
beam arrangement and field size were redesigned for the
new plan to deliver an adequate dose to the targets and to
have a sparing to the critical organs including heart, lung,
and contra-lateral breast. For the original plan, the treat-
ment targets were the CTV-H and PTV. For the new plan,
the targets were represented by PTV-H and PTV.
Statistical analysis
The predictive role of associating factors for higher target
uncertainty was analyzed, and the median values of the
BMFs were used as cut-off points to divide the groups.
The univariate analysis was conducted by the Mann-
Whitney U test or Kruskal-Wallis H test, and the multi-
variant analysis was carried out by multiple regression
analysis via General Linear Model. Comparison between
the two treatment plans with and without PTV-H margin
were done by the Wilcoxon Signed Rank Test. A two-
sided p value of < 0.05 was considered statistically sig-
nificant. All statistical analyses were performed using
a commercial software package (SPSS 19.0 for Windows,
Chicago, IL, USA).
Results
Bony alignment is not correlated well with surgical clip
of tumor bed in patients with breast cancer receiving
dose boost to tumor bed via SIB technique. The displace-
ments of surgical clips and bony anatomy when daily
set-up aligning to skin markers were summarized in
Table 2. The displacement of surgical clip was numerically
larger than bony structures in all orientations except RE in
the CC direction. When aligning to bony anatomy with
daily image guidance, the SE and RE of surgical clips in
AP, CC, LR directions were 2.0, 3.3, 2.7 mm and 1.6, 2.2,
1.9 mm, and the rotational SE and RE was 1.2 and 1.0°,
respectively.
Table 1 Patient and treatment characteristics (N = 60)
Characteristics Number (%)
Age (years) Median (Range) 50 (33-65)




Invasive carcinoma 48 (80%)
Axillary nodal status Negative 60 (100%)
Tumor bed volume (ml) Median (Range) 24.6 (4.4 – 103.9)
Whole breast volume (ml) Median (Range) 429.2 (174.1 – 1205.3)
Breast thickness (cm) Median (Range) 3.01 (1.3 – 6.4)
Body Height (BH) (cm) Median (Range) 158 (147 – 166.8)
Body Weight (BW) (kgs) Median (Range) 57.1 (43.8 – 89)
Body mass index (BMI) Median (Range) 23.1 (18.5 – 34.3)





Abbreviations: UIQ upper inner quadrant, LIQ lower inner quadrant, UOQ
upper outer quadrant, LOQ lower outer quadrant, Sub subareola
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Age, tumor location, and BMFs including body mass
index, volume of the breast, volume of the tumor bed,
and breast thickness were potentially attributable to the
treatment target uncertainty. We analyzed these factors
to evaluate their predictive role. In the univariate
analysis, larger breast thickness had correlation with
greater AP-SE (p = 0.038) and AP-RE (p = 0.006), larger
breast volume was associated with greater AP-RE (p =
0.012), higher BMI had significantly larger AP-RE (p =
0.001) and CC-RE (p = 0.007), and different tumor
locations also had influence on AP-SE (p = 0.039) and
AP-RE (p = 0.011). However, the multivariate analysis
showed that BMI was the only factor having impact on
tumor bed displacement, in AP-RE (p = 0.025), CC-RE
(p = 0.02), and LR-RE (p = 0.001). The details are sum-
marized in Table 3.
According to these results, the 30 patients with higher
BMI (≥ median value: 23.1) were defined as high variation
group for missing boost volume, and the others with lower
BMI were referred as low variation group. When position-
ing was guided with bony structures by on-line image
guidance, the SE’s of surgical clips were 2.4 mm, 3.4 mm,
3.4 mm, 1.3° for high variation group in AP, CC, LR direc-
tions and CR, whereas 1.4 mm, 3.2 mm, 1.8 mm, 1.0° for
low variation group. The RE were 1.9 mm, 2.4 mm, 2 mm,
1.1° for high variation group, while 1.2 mm, 2 mm,
1.6 mm, 0.9° for low variation group. To guarantee that
90% of patients will receive a minimum cumulative dose
Table 2 Summary of set-up errors
Error AP (mm) CC (mm) LR (mm) CR (degree)
Aligning to skin markers
Bony structure SE (∑) 1.6 2.5 2.0 0.7
RE (σ) 1.3 2.6 1.6 0.8
Surgical clip SE (∑) 2.1 2.6 3.2 1.6
RE (σ) 1.6 2.4 2.1 1.2
Aligning to bony structures
Surgical clip SE (∑) 2.0 3.3 2.7 1.2
RE (σ) 1.6 2.2 1.9 1.0
Abbreviations: AP anterior-posterior, CC cranial-caudal, LR left-right, CR couch rotation; SE systematic error, RE random error
Fig. 1 Dose distributions on axial images of CTV-H slices for different patients (up and down), and for the original plan (left) and new plan (right).
According to the location of CTV-H, proper beam arrangement was designed for target coverage and critical organ sparing. Through proper design of
beam arrangement with advanced treatment techniques, the new plan with boost target (PTV-H) shown limited dose increments to heart and lung
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to tumor bed of at least 95% of the prescribed dose,
the corresponding PTV-H margins around tumor
bed according to Van Herk’s formula [16] were
7 mm, 10 mm, and 10 mm in AP, CC, LR directions
for high variation group. For low variation group,
the corresponding margins could be safely reduced
to 4 mm, 9 mm, and 6 mm. The results are listed in
Table 4.
The dosimetric comparison between the original plan
(without PTV-H) and new plan (with PTV-H) are
demonstrated in Table 5 and Fig. 1. In the original plan,
the treatment target coverage was represented by the vol-
ume receiving at least 97% of the prescribed dose, namely
the CTV-H and PTV. In the new plan, the targets were
represented by PTV-H and PTV. There was no significant
difference for mean heart dose or the volume of heart
receiving dose larger than 25 Gy regardless of patients in
high- or low- variation groups, or tumors in left or right
breast. For the ipsilateral lung, mean lung dose, and the
volume of lung receiving at least 5 Gy (V5) or 10 Gy
Table 3 Univariate and multivariate analysis of potential associating factors for larger surgical clip displacement under IGRT
Abbreviations: AP = anterior-posterior; CC = cranial-caudal; LR = left-right; SE = systematic error; RE = random error; * p <0.05
Table 4 Positioning error and corresponding margin for the boost volume in different groups
SE (mm) RE (mm) Corresponding PTV-H margin (mm)
AP CC LR AP CC LR AP CC LR
High variation 2.4 3.4 3.4 1.9 2.4 2.0 7.0 10.0 10.0
Low variation 1.4 3.2 1.8 1.2 2.0 1.6 4.0 9.0 6.0
Abbreviations: AP anterior-posterior, CC cranial-caudal, LR left-right, SE systematic error; RE random error
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(V10) increased significantly for all patient groups. How-
ever, the volume of the ipsilateral lung receiving more
than 20 Gy (V20) showed significant difference only in pa-
tients of high variation group with left side breast cancer.
Discussion
As far as we know, this is the first study to demonstrate the
positional uncertainty of tumor bed in patients with breast
cancer when a SIB technique is implicated. In addition,
we assessed the corresponding PTV-H margin to strat-
ify patients for the high- and low-variation groups, and
to evaluate radiation dose to normal tissue. Our results
indicated that the positional uncertainty of tumor bed
was prominent and could not be ignored during plan-
ning or treatment. Because bony structure is frequently
used as a surrogate for daily image-guided radiotherapy,
Table 5 Dosimetric comparison between plans with and without PTV-H, data given as median (range) for each parameter
Original plan (without PTV-H) New plan (with PTV-H) p value
High variation group patient (BMI≥ 23.1) with left side breast cancer (N = 14)
Tumor bed V97% (%) 99.9 (99, 100) 99.9 (97, 100)
Whole breast V97% (%) 96.4 (93.2, 98) 97.1 (95.3, 98.2)
Ipsilateral lung V5 (%) 27.4 (19.5, 49.1) 28.5 (20, 48.93) 0.002*
Ipsilateral lung V10 (%) 19.4 (12.23, 38.87) 20.1 (12.5, 38.4) 0.006*
Ipsilateral lung V20 (%) 15.1 (8.7, 30.6) 15.2 (8.8, 30.5) 0.013*
Ipsilateral lung mean dose (cGy) 847.4 (549, 1537.5) 889.6 (560, 1549.5) 0.001*
Heart V25 (%) 2.37 (0.29, 9.13) 2.29 (0.24, 11.1) 0.197
Heart mean dose (cGy) 251.7 (150.7, 543.8) 250.5 (160.7, 649) 0.158
High variation group patient (BMI≥ 23.1) with right side breast cancer (N = 10)
Tumor bed V97% (%) 99.96 (99.3, 99.99) 99.6 (98.9, 100)
Whole breast V97% (%) 97.2 (94.7, 98.4) 97.8 (95.5, 98.7)
Ipsilateral lung V5 (%) 30.4 (20.3, 35.6) 31 (20.7, 35.8) 0.005*
Ipsilateral lung V10 (%) 20.5 (12.3, 25.9) 20.74 (12.5, 26.1) 0.005*
Ipsilateral lung V20 (%) 15.9 (7.6, 20.7) 15.9 (7.5, 21) 0.221
Ipsilateral lung mean dose (cGy) 887 (502, 1080.5) 902 (500, 1089) 0.007*
Heart V25 (%) 0 (0, 0) 0 (0, 0) 1
Heart mean dose (cGy) 44.7 (33.8, 66.4) 49.1 (34.6, 66.5) 0.114
Low variation group patient (BMI < 23.1) with left side breast cancer (N = 15)
Tumor bed V97% (%) 100 (98, 100) 100 (97.8, 100)
Whole breast V97% (%) 97.1 (91.7, 98) 97.2 (92, 98.9)
Ipsilateral lung V5 (%) 29.2 (22.4, 36.2) 29.6 (22.6, 32.3) 0.001*
Ipsilateral lung V10 (%) 21.5 (15.6, 27.5) 21.5 (15.9, 27.6) 0.031*
Ipsilateral lung V20 (%) 17 (10.9, 21.7) 16.9 (10.9, 21.8) 0.495
Ipsilateral lung mean dose (cGy) 892.3 (668.6, 1148.7) 909.8 (683.6, 1159) 0.003*
Heart V25 (%) 1.6 (0.04, 4.66) 1.6 (0.05, 4.86) 0.625
Heart mean dose (cGy) 218.8 (95, 374.2) 218.8 (95.9, 381) 0.073
Low variation group patient (BMI < 23.1) with right side breast cancer (N = 9)
Tumor bed V97% (%) 100 (99.9, 100) 100 (99.8, 100)
Whole breast V97% (%) 97.4 (94.2, 98.5) 98 (94.7, 98.5)
Ipsilateral lung V5 (%) 30.6 (21.6, 38.4) 31.7 (22.2, 39) 0.008*
Ipsilateral lung V10 (%) 21.6 (14.2, 26.3) 22.3 (14.5, 26.6) 0.008*
Ipsilateral lung V20 (%) 15.7 (10.4, 19.9) 16.2 (10.7, 19.4) 0.066
Ipsilateral lung mean dose (cGy) 902.3 (623.7, 1099) 929.1 (639.2, 1111) 0.008*
Heart V25 (%) 0 (0, 0) 0 (0, 0) 1
Heart mean dose (cGy) 43.1 (22.8, 53) 43.2 (24, 53.2) 0.05
*p <0.05
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several findings of this study should merit additional
attention.
Daily image guidance with two orthogonal kilovoltage
(KV) plane images is a time-saving and cost-effective
approach, but the correlation of bony anatomy and surgical
clip of tumor bed is a major concern. Dozens of studies
focusing on clip displacement were in use of accelerated
partial breast irradiation technique (APBI). Marco Trovo et
al. [9] reported 15 patients undergoing image-guided partial
breast irradiation with 3 fiducial markers placed in the
tumor bed. Daily orthogonal anterior/posterior and lateral
kV-images were taken before each fraction and compared
with the digitally reconstructed radiographs (DRRs). When
using fiducial markers as the reference, the mean shifts of
the treatment target were 0 mm, 1 mm, 0 mm along
superior/inferior, right/left, and anterior/posterior directions,
meanwhile, the standard deviations were 7 mm, 4 mm,
5 mm, respectively. Park et al. [17] enrolled 26 patients
were treated with 3D conformal APBI, each had three
or four textured gold intraparenchymal fiducials placed
at the periphery of the lumpectomy cavity. The average
variation in daily separation between the fiducial pairs
from daily megavoltage (MV) images was 3 mm± 3 mm.
Thus, they concluded that fiducial markers are stable
throughout the course of APBI, and planning target volume
margins when using bony landmarks should be 10 mm and
can be reduced to 6 mm if using the fiducials.
Nevertheless, there is no compelling data in the litera-
ture in the circumstance of whole breast RT with SIB to
tumor bed. In our analysis, there was no existing
consistency between the displacement of surgical clip
and bony structure. Even the position of bony structure
was corrected by image-guided procedure; the displace-
ment of surgical clips was still not negligible (shown in
Table 2).
In the effort to find which group of patients was prone
to more uncertainty of boost volume, we assessed many
factors including age, tumor location, body mass index,
volume of the breast, volume of the tumor bed, and
breast thickness. Although younger woman tends to
have dense breast tissue, which might render less target
uncertainty during the treatment course, our result did
not show the evidence. Based on this study, location of
tumor, either in one of four quadrants or sub-areola,
breast thickness, and breast volume affected the tumor
bed displacement in AP direction for the univariate ana-
lysis, but none remained a predictor in the multivariate
analysis. In this study, only body mass index did have
statistical significance in multivariate analysis. In con-
trast, a study from Korea comprising 147 patients under-
going weekly IGRT of TomoDirect claimed that breast
size was significantly associated with extensive set up
error in multivariate analysis [18]. Of note, the definition
of breast volume was different from our study. They
estimated the bust and underbust size of patients with a
measuring tape, while we used the CTV on the contour-
ing as a reference.
In this study, patients having a higher BMI were strati-
fied as high-variation group, and need more generous
PTV-H margin of 7 mm, 10 mm, 10 mm in AP, CC, LR
directions. Applying this PTV-H margin around the
tumor bed might be a “double-edged sword”. Since the
long term survival rate for early stage breast cancer was
approaching to more than 90% [19], late complications
in long-term survivors should always be a major con-
cern. Darby et al. reported that the incidence of major
coronary artery events increased linearly with the mean
dose to the heart by 7.4% per gray, irrespective of under-
lying cardiac risk factors [20]. In addition, a prospective
cohort study of about 30000 women showed that radio-
therapy increased mortality from heart disease and lung
cancer 10–20 years afterwards [21].
With respect to dose to organs at risk, a study investi-
gating the effect of image-guided radiotherapy on the
dose distributions in breast boost treatments showed a
modest increase of doses to lung and heart when PTV
margin of tumor bed expanded from 5 mm to 8 mm
[22]. In theory, positional uncertainty of the boost vol-
ume could be mitigated at the expenses of receiving
higher radiation dose to heart and lung. However, our
study showed the dosimetric parameters of heart were
not statistically different between the original and new
plans for high- and low-variation groups. On the other
hand, despite the dosimetric parameters of lung were
generally higher in the new plans, the increment was
limited. Therefore, more generous margin should be
considered for patients with a higher BMI, and it can be
safely applied through proper design of beam arrange-
ment with advanced treatment techniques.
The limitation of the current study was that the impact
of respiratory motion was not investigated. When applying
respiratory-gated or breath-holding techniques; theoretic-
ally, the displacement of surgical clips would be mitigated.
Nevertheless, a recent study [23] consisting of 58 patients
with the analysis of setup errors during deep inspiration
breath-hold (DIBH) disclosed the inter-fraction systematic
error (∑) and random error (σ) was 1.4 mm and 1.7 mm
respectively, which was comparable to those observed in
their previous work for patients irradiated in free breath-
ing (∑ = 1.1 mm, σ = 1.5 mm) [24]. Therefore, they con-
cluded that the main benefit of the DIBH is to separate
the heart from the target rather than irradiating the target
more accurately. Despite they investigated the position of
the chest wall instead of the tumor bed, their result sug-
gested that breathing control might impact little on setup
error during radiotherapy. Additionally, the procedures of
respiratory-gated or breath-holding techniques were time-
consuming and not always suitable for all patients. In the
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era of precision radiotherapy, patients should be treated
with technically acceptable plan with incorporating indi-
vidualized strategy to mitigate treatment uncertainty. If
cone-beam CT is not routinely available or the physician
concerned about the substantial imaging dose, daily
on-board images can provide an accurate, efficient, and
cost-effective way when adequate margin was added to
the tumor bed.
Conclusions
In patients with breast cancer receiving adjuvant radiother-
apy after conservative surgery, a higher BMI is associated
with a greater positional uncertainty of the boost tumor
volume. More generous margin applied to tumor bed
should be considered, and the doses to heart and lung
could be limited through proper design of beam arrange-
ment with advanced treatment techniques. Notably, the
CTV to PTV margins are dependent on reproducibility of
the treatment setup, immobilization, and image guidance.
The margin size must be based on the institutional protocol
that governs the setup variability evaluated at the respective
institution.
Acknowledgements
We thank for the study grants received for projects DMR-106-062 issued by
China Medical University Hospital.
Funding
Not applicable.
Availability of data and materials
The datasets during and/or analyzed during the current study available from
the corresponding author on reasonable request.
Authors’ contributions
PL, CL, and AS were responsible for design of the study, acquisition, analysis
and interpretation of data, and drafting the article. SC, CC, CC, HH, JL, and YL
provided some intellectual content. AC Shiau approved the version to be
submitted. All authors read and approved the final manuscript.
Competing interests
The authors declared that they have no competing interests.
Consent for publication
Not applicable, no identifiable individual patient data.
Ethics approval and consent to participate
This retrospective study was approved by ethic committee of China Medical
University Hospital (project number CMUH105-REC-3-064).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Radiation Oncology, China Medical University Hospital, 2nd
Yu-De Road, North District, Taichung City, Taiwan. 2Department of Medicine,
China Medical University, Taichung, Taiwan. 3Department of Medicine, Taipei
Medical University, Taipei, Taiwan. 4Department of Biomedical Imaging and
Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.
Received: 8 September 2016 Accepted: 14 March 2017
References
1. Van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et
al. Long-term results of a randomized trial comparing breast-conserving
therapy with mastectomy: european organization for research and
treatment of cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143–50.
2. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of
radiotherapy and of differences in the extent of surgery for early breast
cancer on local recurrence and 15-year survival: an overview of the
randomised trials. Lancet. 2005;366:2087–106.
3. Bartelink H, Horiot J-C, Poortmans PM, Struikmans H, Van den Bogaert W,
Fourquet A, et al. Impact of a higher radiation dose on local control and
survival in breast-conserving therapy of early breast cancer: 10-year results
of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin
Oncol. 2007;25:3259–65.
4. Coon AB, Dickler A, Kirk MC, Liao Y, Shah AP, Strauss JB, et al. Tomotherapy
and multifield intensity-modulated radiotherapy planning reduce cardiac
doses in left-sided breast cancer patients with unfavorable cardiac anatomy.
Int J Radiat Oncol Biol Phys. 2010;78:104–10.
5. Schubert LK, Gondi V, Sengbusch E, Westerly DC, Soisson ET, Paliwal BR, et
al. Dosimetric comparison of left-sided whole breast irradiation with 3DCRT,
forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and
topotherapy. Radiother Oncol. 2011;100:241–6.
6. Jagsi R, Moran J, Marsh R, Masi K, Griffith KA, Pierce LJ. Evaluation of four
techniques using intensitymodulated radiation therapy for comprehensive
locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys. 2010;
78:1594–603.
7. Goddu SM, Chaudhari S, Mamalui-Hunter M, Pechenaya OL, Pratt D, Mutic S,
et al. Helical tomotherapy planning for left-sided breast cancer patients with
positive lymph nodes: comparison to conventional multiport breast
technique. Int J Radiat Oncol Biol Phys. 2009;73:1243–51.
8. Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer
R, et al. Volumetric modulated arc therapy improves dosimetry and reduces
treatment time compared to conventional intensity-modulated
radiotherapy for locoregional radiotherapy of left-sided breast cancer and
internal mammary nodes. Int J Radiat Oncol Biol Phys. 2010;76:287–95.
9. Trovo M, Polesel J, Biasutti C, Sartor G, Roncadin M, Trovo GM. Fiducial
markers for image-guided partial breast irradiation. Radiol Med. 2013;118:
1212–9.
10. Yue NJ, Haffty BG, Kearney T, Kirstein L, Chen SGoyal S. Tracking the
dynamic seroma cavity using fiducial markers in patients treated with
accelerated partial breast irradiation using 3D conformal radiotherapy. Med
Phys. 2013;40:021717.
11. Ippolito E, Trodella L, Silipigni S, D’Angelillo RM, Di Donato A, Fiore M, et al.
Estimating the value of surgical clips for target volume delineation in
external beam partial breast radiotherapy. Clin Oncol. 2014;26:677–83.
12. Sung SY, Lee JH, Lee JH, Kim SH, Kwak YK, Lee SW, et al. Displacement of
surgical clips during postoperative radiotherapy in breast cancer patients
Who received breast-conserving surgery. J Breast Cancer. 2016;19:417–22.
13. Tanaka H, Hayashi S, Hoshi H. Determination of the optimal method for the
field-in-field technique in breast tangential radiotherapy. J Radiat Res. 2014;
55:769–73.
14. Julia White, An Tai, Douglas Arthur, Thomas Buchholz, Shannon
MacDonald, Lawrence Marks, Lori Pierce, et al. Breast Cancer Atlas for
Radiation Therapy Planning: Consensus Definitions. https://www.rtog.
org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx .
15. Van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;
14:52–64.
16. Van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct
target dosage: dose-population histograms for deriving treatment margins
in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121–35.
17. Park CK, Pritz J, Zhang GG, Forster KM, Harris EE. Validating fiducial markers
for image-guided radiation therapy for accelerated partial breast irradiation
in early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:425–31.
18. Chung MJ, Lee GJ, Suh YJ, Lee HC, Lee SW, Jeong S, et al. Setup error and
effectiveness of weekly image-guided radiation therapy of TomoDirect for
early breast cancer. Cancer Res Treat. 2015;47:774–80.
19. Surveillance, Epidemiology, and End Results Program. 2006-2012.
Lee et al. Radiation Oncology  (2017) 12:55 Page 8 of 9
20. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D,
et al. Risk of ischemic heart disease in women after radiotherapy for breast
cancer. N Engl J Med. 2013;368:987–98.
21. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart
disease and lung cancer after radiotherapy for early breast cancer:
prospective cohort study of about 300,000 women in US SEER cancer
registries. Lancet Oncol. 2005;6:557–65.
22. Donovan EM, Brooks C, Mitchell RA, Mukesh M, Coles CE, Evans PM, et al.
The effect of image guidance on dose distributions in breast boost
radiotherapy. Clin Oncol (R Coll Radiol). 2014;26:671–6.
23. Lutz CM, Poulsen PR, Fledelius W, Offersen BV, Thomsen MS. Setup error
and motion during deep inspiration breath-hold breast radiotherapy
measured with continuous portal imaging. Acta Oncol. 2016;55:193–200.
24. Thomsen MS, Harrov U, Fledelius W, Poulsen PR. Inter- and intra-fraction
geometric errors in daily image-guided radiotherapy of free-breathing
breast cancer patients measured with continuous portal imaging. Acta
Oncol. 2014;53:802–8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lee et al. Radiation Oncology  (2017) 12:55 Page 9 of 9
